Based on the Maravai Lifesciences Holdings Inc stock forecast from 5 analysts, the average analyst target price for Maravai Lifesciences Holdings Inc is USD 9.21 over the next 12 months. Maravai Lifesciences Holdings Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Maravai Lifesciences Holdings Inc is Neutral, which is based on 6 positive signals and 7 negative signals. At the last closing, Maravai Lifesciences Holdings Inc’s stock price was USD 4.24. Maravai Lifesciences Holdings Inc’s stock price has changed by -11.11% over the past week, -12.58% over the past month and -23.19% over the last year.
No recent analyst target price found for Maravai Lifesciences Holdings Inc
No recent average analyst rating found for Maravai Lifesciences Holdings Inc
Company Overview Maravai Lifesciences Holdings Inc
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California. Read Less
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical developme...Read More
Frequently Asked Questions About Maravai Lifesciences Holdings Inc (MRVI) Stock
Based on ratings from 5 analysts Maravai Lifesciences Holdings Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 3 buy, 1 sell and 2 hold ratings.
Unfortunately we do not have enough data on MRVI's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for MRVI is USD 9.21 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 4.25.
MRVI stock's Price/Earning ratio is 29.83.
Our analysis grades MRVI stock's Price / Earning ratio at F. This means that MRVI stock's Price/Earning ratio is above 78% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this MRVI may be a overvalued for its sector.
The last closing price of MRVI's stock was USD 4.24.
The most recent market capitalization for MRVI is USD 1.25B.
Based on targets from 5 analysts, the average taret price for MRVI is projected at USD 9.21 over the next 12 months.
This means that MRVI's stock price may go up by +117.18% over the next 12 months.
We can't find any ETFs which contains Maravai Lifesciences Holdings Inc's stock.
As per our most recent records Maravai Lifesciences Holdings Inc has 580 Employees.
Maravai Lifesciences Holdings Inc's registered address is 10770 Wateridge Circle, San Diego, CA, United States, 92121.
You can get more information about it from Maravai Lifesciences Holdings Inc's website at https://www.maravai.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Maravai Lifesciences Holdings Inc (MRVI) Stock
Based on ratings from 5 analysts Maravai Lifesciences Holdings Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 3 buy, 1 sell and 2 hold ratings.
Unfortunately we do not have enough data on MRVI's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for MRVI is USD 9.21 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 4.25.
MRVI stock's Price/Earning ratio is 29.83.
Our analysis grades MRVI stock's Price / Earning ratio at F. This means that MRVI stock's Price/Earning ratio is above 78% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this MRVI may be a overvalued for its sector.
The last closing price of MRVI's stock was USD 4.24.
The most recent market capitalization for MRVI is USD 1.25B.
Based on targets from 5 analysts, the average taret price for MRVI is projected at USD 9.21 over the next 12 months.
This means that MRVI's stock price may go up by +117.18% over the next 12 months.
We can't find any ETFs which contains Maravai Lifesciences Holdings Inc's stock.
As per our most recent records Maravai Lifesciences Holdings Inc has 580 Employees.
Maravai Lifesciences Holdings Inc's registered address is 10770 Wateridge Circle, San Diego, CA, United States, 92121.
You can get more information about it from Maravai Lifesciences Holdings Inc's website at https://www.maravai.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MRVI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
